Tofacitinib Citrate
Brand name: Xeljanz Xr
Rank #59 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$294.4M
Total Cost
49,478
Total Claims
$294.4M
Total Cost
1,925
Prescribers
$5,950
Cost per Claim
948
Beneficiaries
53,123
30-Day Fills
$153K
Avg Cost/Provider
26
Avg Claims/Provider
Share of Medicare Part D Spending
0.11%
of total Medicare Part D spending
$294.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $294.4M total
🔎 Data Overview
At $5,950 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $152,934 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $310,547 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Tofacitinib Citrate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Faisal Chaudhary | Internal Medicine | Saratoga Springs, NY | 212 | $1.3M |
| 2 | James Gore | Rheumatology | Nashville, TN | 209 | $1.3M |
| 3 | Ulker Tok | Rheumatology | Tucson, AZ | 197 | $1.2M |
| 4 | Yousong Wang | Rheumatology | New Britain, CT | 118 | $821K |
| 5 | Sailaja Manne | Internal Medicine | San Antonio, TX | 131 | $787K |
| 6 | Amarilis Torres | Rheumatology | Zephyrhills, FL | 129 | $786K |
| 7 | Jo Feugate | Rheumatology | Springfield, MO | 114 | $744K |
| 8 | Jyothi Mallepalli | Rheumatology | Monroe, LA | 127 | $724K |
| 9 | Luisana Gomez | Physician Assistant | Monterey Park, CA | 123 | $701K |
| 10 | Andrew Porges | Rheumatology | New Hyde Park, NY | 80 | $694K |
| 11 | Gary Solomon | Internal Medicine | New York, NY | 113 | $675K |
| 12 | Suzana Morgan | Rheumatology | East Brunswick, NJ | 113 | $672K |
| 13 | Timothy Moore | Rheumatology | Albuquerque, NM | 119 | $664K |
| 14 | Kristine Rea | Rheumatology | Anderson, IN | 83 | $627K |
| 15 | Srikanth Naramala | Rheumatology | Hanford, CA | 86 | $617K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 56 | Albuterol Sulfate (Albuterol Sulfate Hfa) | $312.2M | 7,904,120 |
| 57 | Rifaximin (Xifaxan) | $310.0M | 111,328 |
| 58 | Sitagliptin Phos/Metformin Hcl (Janumet) | $302.2M | 329,315 |
| 59 | Tofacitinib Citrate (Xeljanz Xr) | $294.4M | 49,478 |
| 60 | Umeclidinium Brm/Vilanterol Tr (Anoro Ellipta) | $294.3M | 480,651 |
| 61 | Gabapentin (Gabapentin) | $291.0M | 15,142,335 |
| 62 | Cabozantinib S-Malate (Cabometyx) | $287.3M | 11,285 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology